The US-listed company LIXTE has invested $2.6 million in cryptocurrency, increasing its allocation ratio to 50%

ChainCatcher news, Nasdaq-listed company LIXTE Biotechnology Holdings (stock codes: LIXT and LIXTW) announced on September 10 that it has purchased 10.5 Bitcoin and 300 Ethereum for a total value of approximately $2.6 million as part of its diversification strategy.

According to the announcement, cryptocurrencies currently account for 43.6% of LIXTE's capital holdings, and the company's board has approved increasing the allocation of cryptocurrency to 50%. LIXTE Chairman and CEO Geordan Pursglove stated that this move aims to build a balanced and flexible digital asset strategy, enhancing the company's adaptability and long-term growth potential in the digital economy. Previously, it was reported that the U.S. listed biotech company LIXTE plans to allocate up to 25% of its capital reserves to digital assets such as Bitcoin.